Articles by author - Jaromír Svestka

Sleep deprivation therapy.

Svestka J.

Journal Article 2008; 29(Suppl 1): 65-92 PubMed PMID: 19029872  Keywords:  Antipsychotic Agents:therapeutic use, Circadian Rhythm:physiology, Clinical Trials as Topic, Combined Modality Therapy, Depressive Disorder:physiopathology, Flumazenil:therapeutic use, GABA Modulators:therapeutic use, Humans, Lithium Compounds:therapeutic.    Citation

: Sleep deprivation is a useful therapeutic option in the treatment of depressive disorders, especially in pharmacoresistant disorders. It.....

Read abstract

Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.

Svestka J, Synek O, Tomanová J, Rodáková I, Cejpková A.

Clinical Trial 2007; 28(6): 881-888 PubMed PMID: 18063941  Keywords:  Adolescent, Adult, Aged, Aged, 80 and over, Antipsychotic Agents:adverse effects, Benzodiazepines:adverse effects, Dibenzothiazepines:adverse effects, Dibenzothiepins:adverse effects, Female, Humans, Hyperprolactinemia:blood, Middle Aged, Prolactin:blood,.    Citation

OBJECTIVES: The main objective was to evaluate the effect of five second-generation antipsychotics (amisulpride, quetiapine, olanzapine, r.....

Read abstract  Full text PDF

Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.

Svestka J, Bitter I.

Journal Article 2007; 28(Suppl 1): 95-116 PubMed PMID: 17262005  Keywords:  Antipsychotic Agents:metabolism, Humans, Patient Compliance, Risk Factors, Schizophrenia:drug therapy, Schizophrenic Psychology, Treatment Refusal,.    Citation

: Adherence to treatment is a general indicator of quality and success of communication between the physician and the patient. It means th.....

Read abstract  Full text PDF